Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

TBPH

Theravance Biopharma, Inc.

CIK 0001583107 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$16.98
↓ 0.02 (-0.12%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership; Excluded: Options (no data)

Key stats

Market Cap
$875.37M
P/E Ratio
Not covered
EPS
2.10
Dividend Yield
Not covered
52W Position
60%
Beta
0.68

Valuation multiples

Fwd P/E
7.91
PEG
-0.05
P/B
3.01
P/S
Not covered
EV/Revenue
Not covered
ROE
Not covered
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 60%
$10.82$21.03

Latest Financials

2025-12-31 FY
Revenue
$107.46M
Net Income
$105.89M
Total Assets
$485.57M
Free Cash Flow
–

Recent news